Teladoc Health (TDOC) Net Margin (2014 - 2026)

Teladoc Health has disclosed Net Margin across 13 years of filings, most recently posting 6.41% for Q2 2026.

• In Q2 2026, Net Margin fell 125.0% year-over-year to 6.41%; the TTM figure through Jun 2026 stood at 7.13% (up 103.0% YoY), while the FY2025 annual figure was 7.92%, up 3105.0% from the prior year.
• Net Margin came in at 6.41% for Q2 2026 at Teladoc Health, up from 10.4% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 3.91% in Q4 2025 to a low of 1180.6% in Q1 2022.
• Average Net Margin over 5 years is 141.78%, with a median of 10.19% recorded in 2026.
• Year-over-year, Net Margin tumbled 113660 bps in 2022 and jumped 116960 bps in 2023.
• Over 5 years, Net Margin stood at 597.47% in 2022, then soared by 99 bps to 4.38% in 2023, then plunged by 72 bps to 7.55% in 2024, then surged by 48 bps to 3.91% in 2025, then sank by 64 bps to 6.41% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 6.41% in Q2 2026, 10.4% in Q1 2026, and 3.91% in Q4 2025.